Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer

Completed · Phase 2

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as liposomal SN-38, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well liposomal SN-38 works in treating patients with metastatic colorectal cancer.

Key facts

Study ID

NCT00311610

Run by

Alliance for Clinical Trials in Oncology

People needed

30

Starts

2006-01-01

Expected to finish

2010-06-01

Last updated by the study team

2016-06-29

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Kaiser Permanente Medical Office -Vandever Medical Office — San Diego, California, United States
• Tunnell Cancer Center at Beebe Medical Center — Lewes, Delaware, United States
• CCOP - Christiana Care Health Services — Newark, Delaware, United States
• Union Hospital Cancer Program at Union Hospital — Elkton MD, Maryland, United States
• University Medical Center of Southern Nevada — Las Vegas, Nevada, United States
• CCOP - Nevada Cancer Research Foundation — Las Vegas, Nevada, United States
• Cancer Institute of New Jersey at Cooper - Voorhees — Voorhees Township, New Jersey, United States
• Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina, United States
• Kinston Medical Specialists — Kinston, North Carolina, United States
• Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.